Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Sales | 2,469,551 | 395,600 | 78,858 | 45,984 | 30,518 |
| Cost of Goods | 281,025 | 47,101 | 7,996 | 6,234 | 6,445 |
| Gross Profit | 2,188,526 | 348,499 | 70,862 | 39,750 | 24,073 |
| Operating Expenses | 184,603 | 70,344 | 289,739 | 129,109 | 89,912 |
| Operating Income | 2,003,948 | 278,255 | -217,881 | -89,125 | -65,394 |
| Interest Expense | 53,890 | 37,579 | 25,289 | 10,752 | 572 |
| Other Income | 29,899 | -6,072 | 554 | 226 | 7,079 |
| Pre-tax Income | 1,979,957 | 234,604 | -242,615 | -99,652 | -58,887 |
| Income Tax | 619,920 | -184,402 | 2,912 | -2,429 | 9 |
| Net Income Continuous | 1,360,037 | 419,006 | -245,527 | -97,223 | -58,895 |
| Net Income | $1,360,037 | $419,006 | $-245,527 | $-97,223 | $-58,895 |
| EPS Basic Total Ops | 5.59 | 1.78 | -1.03 | -0.42 | -0.26 |
| EPS Basic Continuous Ops | 5.59 | 1.79 | -1.03 | -0.42 | -0.26 |
| EPS Diluted Total Ops | 5.29 | 1.78 | -1.03 | -0.42 | -0.26 |
| EPS Diluted Continuous Ops | 5.29 | 1.78 | -1.03 | -0.42 | -0.26 |
| EBITDA(a) | $2,019,621 | $291,882 | $-206,437 | $-79,418 | $-55,915 |